FDA Approves Givosiran for Acute Hepatic Porphyria
Nov 20
2019
The Food and Drug Administration approved givosiran (GIVLAARI, Alnylam Pharmaceuticals, Inc.) for adults with acute hepatic porphyria (AHP).